Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Laboratoire M2 raises $4.6 million
by Melody M. Bomgardner
May 22, 2017
| A version of this story appeared in
Volume 95, Issue 21
Sherbrooke, Quebec-based start-up Laboratoire M2 has raised $4.6 million for its Thymox disinfectant technology in a second round of venture funding from Cycle Capital Management, Desjardins Innovatech, and others. The company will use the funds to commercialize its botanical products for use in crop protection, animal health, and cleaning markets. Thymox products are made from thymol, derived from the thyme plant. Laboratoire M2 says the products kill pathogenic microbes without harming tissue or the environment and are biodegradable and nontoxic.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter